Â鶹´«Ã½ÉçÇø

Performance Metrics

The ultimate measure of our performance is the impact on society through our commercialization efforts. Early performance indicators include funds received, transactions entered into and relationships established and maintained.

Licensing revenue is an indication that there are Laboratorytechnologies reaching the public through product sales or that there has been a recognition of value by companies and investors in the form of license fees. Collaborative research transactions contribute to the funding portfolio of Laboratoryand represent a commitment from our partners in a line of scientific inquiry. Transctions of all forms enable commercialization, illustrate interest and/or represent a commitment for a long-term investment in taking our discoveries forward.

For LaboratoryScientists

Technology Transfer Process

Our Scientist’s Guide to Technology Transfer outlines key elements of the technology transfer process at Â鶹´«Ã½ÉçÇø.

This guide answers the most common questions we receive from Â鶹´«Ã½ÉçÇø’s research community and provides an overview of the technology transfer process and services available for our scientists.

Download the Guide here. Alternatively, printed and bound copies are available from the Office of Technology Transfer.

Scientist Guide

Commercial Relations

Engagement with industry and commercial relationships are governed by Â鶹´«Ã½ÉçÇø’s Commercial Relations Policy.
Carefully structured and constructive relationships between Â鶹´«Ã½ÉçÇø, as an institution engaged in basic scientific research, and various organizations primarily engaged in commerce can result in numerous important benefits, including a fair financial reward from intellectual property put to commercial use for the public good and enhanced resources for Laboratoryand its scientists. Nonetheless, there can be significant dangers and potential conflicts of interest that arise from improperly structured or conducted relationships between Â鶹´«Ã½ÉçÇø, its staff and outside parties. For that reason, Â鶹´«Ã½ÉçÇø’s Commercial Relations Policy is designed to encourage scientifically meritorious and productive interactions between Â鶹´«Ã½ÉçÇø, its staff and commercial organizations, while protecting Â鶹´«Ã½ÉçÇø’s intellectual property interests and reputation, and avoiding undue restrictions upon intellectual freedom or upon the useful dissemination of Â鶹´«Ã½ÉçÇø’s research in the public interest. Our Office of Technology Transfer is the primary level administrator of these policies. If you have any questions about Â鶹´«Ã½ÉçÇø’s Commercial Relations Policy, please contact us.

Technology Disclosure

If you are a Laboratoryscientist and think the results of your research have commercial potential, please come talk with us. We will discuss completing a Technology Disclosure Form and address any questions you have about our process.

A Technology Disclosure is a written description of your invention that is provided to the Office of Technology Transfer. Completing a Technology Disclosure Form is the first formal step in a process that could lead to commercialization of your technology. Our Guide also provides some details on this process.

Technology Disclosure Form

Material Transfer

The exchange of research materials is an essential part of scientific research. It promotes effective collaboration among Laboratoryscientists and their counterparts in academia, government and industry.

Material Transfer Agreements (MTAs) are legal contracts which set out each party’s expectations and obligations regarding the exchange of materials, including issues relating to publication of research results, further distribution of the materials, and modification and rights of the provider and the recipient in any inventions made with the materials.

MTAs are processed through the Office of Technology Transfer. Please contact our office as soon as possible when planning to receive or send materials as some MTAs may require time for negotiation.

In order to expedite your request, please have the following information ready:

1. Name of Laboratoryproviding or requesting scientist
2. Name of external providing or requesting scientist and institution
3. Name and type of material and description of intended use
4. Name of authorized official from recipient institution (must be someone in their technology transfer office)
5. Any other specifics, such as associated fees
6. For incoming materials, all sources of funding (government and private) that will be used to support the research using the requested materials

Laboratoryis engaged with AUTM in a program to streamline MTA use.

AUTM-MTA templates

Conflict of Interest Policy

The Investigator Conflict of Interest Policy sets forth specific procedures for annual disclosure and review of significant financial interests so that, as an institution, the highest standards of integrity and objectivity are applied to the design, conduct and reporting of research carried out at or by Â鶹´«Ã½ÉçÇø.

Conflict of Interest Policy

Consulting

Consulting agreements are private contracts between investigators and companies outside the scope of Laboratoryemployment. Investigators have an obligation to familiarize themselves with Â鶹´«Ã½ÉçÇø’s policies relevant to consulting activities before entering into any such arrangement.
All consulting agreements entered into by Laboratoryscientists must incorporate our Uniform Consulting Agreement Provisions.

Consulting Agreement Provisions

For Industry/Investors

Core principles when engaging with industry

• Flexibility to carry out fundamental research – basic research is the source of the most disruptive and novel discoveries and critical to our mission in adding to the base of knowledge.
• Uncompromised student experience – post docs and students must be able to publish and discuss their work.
• Publishing to add to the base of knowledge – it is core to Â鶹´«Ã½ÉçÇøs mission.
• Preserving a scientist’s right to follow his/her line of inquiry – regardless of what is transferred, rights must be retained for this purpose.
• Unfettered access of research tools – also important to the base of knowledge.
• Commercialization for the benefit of society – diligent commercialization (no shelving of inventions) is core to dissemination of research results for the benefit of society.
• Recognition of individual and institution contributions to commercial outcomes – it’s our responsibility to capture a fair return and irresponsible not to as all returns are used in supporting innovation and Â鶹´«Ã½ÉçÇø’s mission.
• Managing proprietary information of the company and that pertaining to new inventions – a daunting task in an academic environment may not be the right place for the most sensitive confidential information.
• Meeting obligations to all research sponsors – many discoveries are the result of support from multiple sources.
• Covering the cost of research – the costs of industry research should be fully covered by the collaborative partner not school fees, other sponsors, etc.

Licensing

Â鶹´«Ã½ÉçÇø’s world-renowned research programs span Cancer, Neuroscience, Plant Biology, Quantitative Biology and Bioinformatics & Genomics. Â鶹´«Ã½ÉçÇø’s research environment is highly collaborative, allowing Laboratoryscientists to work together across disciplines to solve biology’s most challenging problems, with the ultimate goal of benefiting the public by advancing this research to improve the diagnosis and treatment of cancer, neurological disorders and other diseases. With that goal in mind, Laboratorygrants licenses to existing and startup companies that demonstrate the technical and financial capabilities to develop our early-stage technology into commercially successful products. Companies are encouraged to discuss their business interests with our Office of Technology Transfer so we can bring the Laboratoryinventions and prominent investigators in their areas of interest to their attention.

Faculty Guide

Â鶹´«Ã½ÉçÇø’s Faculty Guide provides an introduction to the areas of research interest for each member of our faculty.

Material Transfer Agreements

The Office of Technology Transfer supports Laboratoryscientists with agreements to transfer proprietary materials into and out of Laboratorythrough Material Transfer Agreements as well as tangible material licensing arrangements.

shRNA Technology Licenses

Laboratoryresearch has played a major role in developing short hairpin RNAs (shRNAs) as important biomedical research tools that we wish to see distributed and used broadly. Revenue from our licensing program provides an important source of support for continued improvement and development of shRNA-based research tools at Â鶹´«Ã½ÉçÇø. Academic and government institutions are free to utilize the shRNA technology only for their internal research use. This grant of rights specifically excludes the right to sell shRNA reagents, or to otherwise transfer shRNA reagents for any commercial use.

Commercial distributors that wish to sell shRNA reagents and services to the research community and for-profit companies that wish to use this patented shRNA technology in their research should contact Â鶹´«Ã½ÉçÇø’s shRNA licensing agent Hairpin Technologies, Inc. at licensing@hairpintechnologies.com for more information. Non-exclusive licenses are available for these purposes for a modest fee.

For-profit companies interested in obtaining a license to use Â鶹´«Ã½ÉçÇø’s shRNA technology for therapeutic or diagnostic purposes should contact our Office of Technology Transfer at 516-367-8301 or techtran@cshl.edu.

Sponsored Research

Â鶹´«Ã½ÉçÇø’s preferred sponsored research arrangements with industry follow our Uniform SRA format.